PapersPMID:28753932
Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“When we compared PFS and OS between placebo and red ginseng groups, the mean values of PFS were 34.4 and 39.2 months in placebo and red ginseng groups, showing no difference (p = 0.448).”
- Study
- RCT
- Participants
- 30
- Duration
- 3 months
- Dose studied
- two 500 mg capsules three times a day (3000 mg per day) for three months
- Population
- Women with epithelial ovarian cancer who had completed six cycles of adjuvant taxane- and platinum-based chemotherapy with complete or partial response, 15 per arm
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Patients with epithelial ovarian cancer (EOC) after cytoreductive surgery and six cycles of adjuvant taxane- and platinum-based chemotherapy; Korean red ginseng (steamed Panax ginseng Meyer, 6-year-old)
- Participants
- 30
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 17